Gestational hypertension in atrial natriuretic peptide knockout mice and the developmental origins of salt-sensitivity and cardiac hypertrophy

Regulatory Peptides

Volumn 186, Issue , 2013, Pages 108-115

  Armstrong, David W J ^a,b   Tse, M Yat ^a   O'Tierney Ginn, Perrie F ^c   Wong, Philip G ^a   Ventura, Nicole M ^a   Janzen Pang, Judy J ^a   Matangi, Murray F ^b   Johri, Amer M ^d   Croy, B Anne ^a   Adams, Michael A ^a   Pang, Stephen C ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b Kingston Heart Clinic   (Canada)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d KINGSTON GENERAL HOSPITAL   (Canada)

Author keywords

Cardiac hypertrophy; Developmental origins; Hypertension; Natriuretic peptides; Salt sensitivity

Indexed keywords

ATRIAL NATRIURETIC FACTOR; NATRIURETIC PEPTIDE RECEPTOR A;

ADULT ANIMAL; AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HETEROZYGOTE; KIDNEY; KNOCKOUT MOUSE; MALE; MATERNAL HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BINDING; SALT INTAKE; SALT SENSITIVITY; TELEMETRY;

ANP; ATRIAL NATRIURETIC PEPTIDE; B-TYPE NATRIURETIC PEPTIDE; BLOOD PRESSURE; BNP; BP; CARDIAC HYPERTROPHY; CARDIOVASCULAR; CARDIOVASCULAR DISEASE; CV; CVD; DEVELOPMENTAL ORIGINS; EIA; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENOS; ENZYME IMMUNOASSAY; HIGH SALT; HS; HYPERTENSION; INTRAUTERINE GROWTH RESTRICTION; IUGR; LEFT VENTRICLE; LV; NATRIURETIC PEPTIDE PRECURSOR A GENE; NATRIURETIC PEPTIDE RECEPTOR 1 GENE; NATRIURETIC PEPTIDE RECEPTOR 3 GENE; NATRIURETIC PEPTIDE RECEPTOR A; NATRIURETIC PEPTIDE RECEPTOR C; NATRIURETIC PEPTIDE SYSTEM; NATRIURETIC PEPTIDES; NORMAL SALT; NPPA; NPR-A; NPR-C; NPR1; NPR3; NPS; NS; PDE; PHOSPHODIESTERASE; RADIOIMMUNOASSAY; RIA; SALT-SENSITIVITY;

ANIMALS; ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; FEMALE; FETAL DEVELOPMENT; GENE EXPRESSION; GENE EXPRESSION REGULATION; HYPERTENSION, PREGNANCY-INDUCED; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; P300-CBP TRANSCRIPTION FACTORS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROTO-ONCOGENE PROTEIN C-ETS-1; RECEPTORS, ATRIAL NATRIURETIC FACTOR; SALT-TOLERANCE; SODIUM, DIETARY; VENTRICULAR REMODELING;

EID: 84883685850     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2013.08.006     Document Type: Article

References (57)

1. Molkentin J.D. A friend within the heart: natriuretic peptide receptor signaling. J Clin Invest 2003, 111:1275-1277.
2. Potter L.R., bbey-Hosch S., Dickey D.M. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 2006, 27:47-72.
3. John S.W., Krege J.H., Oliver P.M., Hagaman J., Hodgin J.B., Pang S.C., Flynn T.G., Smithies O. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 1995, 267:679-681.
4. Feng J.A., Perry G., Mori T., Hayashi T., Oparil S., Chen Y.F. Pressure-independent enhancement of cardiac hypertrophy in atrial natriuretic peptide-deficient mice. Clin Exp Pharmacol Physiol 2003, 30:343-349.
5. Hamet P., Tremblay J., Pang S.C., Garcia R., Thibault G., Gutkowska J., Cantin M., Genest J. Effect of native and synthetic atrial natriuretic factor on cyclic GMP. Biochem Biophys Res Commun 1984, 123:515-527.
6. Soares T.J., Coimbra T.M., Martins A.R., Pereira A.G.F., Carnio E.C., Branco L.G.S., buquerque-Araujo W.I.C., De Nucci G., Favaretto A.L.V., Gutkowska J. Atrial natriuretic peptide and oxytocin induce natriuresis by release of cGMP. Proc Natl Acad Sci U S A 1999, 96:278-283.
7. Sangaralingham S.J., Tse M.Y., Pang S.C. Estrogen protects against the development of salt-induced cardiac hypertrophy in heterozygous proANP gene-disrupted mice. J Endocrinol 2007, 194:143-152.
8. Sangaralingham S.J., Tse M.Y., Pang S.C. Estrogen delays the progression of salt-induced cardiac hypertrophy by influencing the renin-angiotensin system in heterozygous proANP gene-disrupted mice. Mol Cell Biochem 2007, 306:221-230.
9. Kristensen C.G., Nakagawa Y., Coe F.L., Lindheimer M.D. Effect of atrial natriuretic factor in rat pregnancy. Am J Physiol Regul Integr Comp Physiol 1986, 250:R589-R594.
10. Nissel H., Carlström K., Cizinsky S., Grunewald C., Nylund L., Randmaa I. Atrial natriuretic peptide concentrations and hemodynamic effects of acute plasma volume expansion in normal pregnancy and preeclampsia. Obstet Gynecol 1992, 79:902-907.
11. Sala C., Campise M., Ambroso G., Motta T., Zanchetti A., Morganti A. Atrial natriuretic peptide and hemodynamic changes during normal human pregnancy. Hypertension 1995, 25:631-636.
12. Knight S., Snellen H., Humphreys M., Baylis C. Increased renal phosphodiesterase-5 activity mediates the blunted natriuretic response to ANP in the pregnant rat. Am J Physiol Renal Physiol 2007, 292:F655-F659.
13. Stebbing P.N., Gude N.M., King R.G., Brennecke S.P. Atrial natriuretic peptide-induced attenuation of vasoconstriction in the fetal circulation of the human isolated perfused placenta. J Perinat Med 1996, 24:253-260.
14. Holcberg G., Kossenjans W., Brewer A., Miodovnik M., Myatt L. The action of two natriuretic peptides (atrial natriuretic peptide and brain natriuretic peptide) in the human placental vasculature. Am J Obstet Gynecol 1995, 172:71-77.
15. Holcberg G., Kossenjans W., Brewer A., Miodovnik M., Myatt L. Selective vasodilator effects of atrial natriuretic peptide in the human placental vasculature. J Soc Gynecol Investig 1995, 2:1-5.
16. Graham C.H., Watson J.D., Blumenfeld A.J., Pang S.C. Expression of atrial natriuretic peptide by third-trimester placental cytotrophoblasts in women. Biol Reprod 1996, 54:834-840.
17. Lim A.T., Gude N.M. Atrial natriuretic factor production by the human placenta. J Clin Endocrinol Metab 1995, 80:3091-3093.
18. Chan J.C.Y., Knudson O., Wu F., Morser J., Dole W.P., Wu Q. Hypertension in mice lacking the proatrial natriuretic peptide convertase corin. Proc Natl Acad Sci U S A 2005, 102:785-790.
19. Cui Y., Wang W., Dong N., Lou J., Srinivasan D.K., Cheng W., Huang X., Liu M., Fang C., Peng J. Role of corin in trophoblast invasion and uterine spiral artery remodelling in pregnancy. Nature 2012, 484:246-250.
20. McQueen J., Kingdom J.C.P., Jardine A.G., Connell J.M.C., Whittle M.J. Vascular angiotensin II and atrial natriuretic peptide receptors in normal and growth-retarded human placentae. J Endocrinol 1990, 126:341-347.
21. Cameron V.A., Ellmers L.J. Minireview: natriuretic peptides during development of the fetal heart and circulation. Endocrinology 2003, 144:2191-2194.
22. Alexander B.T. Placental insufficiency leads to development of hypertension in growth-restricted offspring. Hypertension 2003, 41:457-462.
23. McArdle H.J., Andersen H.S., Jones H., Gambling L. Fetal programming: causes and consequences as revealed by studies of dietary manipulation in rats - a review. Placenta 2006, 27:56-60.
24. Ojeda N.B., Grigore D., Robertson E.B., Alexander B.T. Estrogen protects against increased blood pressure in postpubertal female growth restricted offspring. Hypertension 2007, 50:679-685.
25. Ojeda N.B., Grigore D., Alexander B.T. Developmental programming of hypertension: insight from animal models of nutritional manipulation. Hypertension 2008, 52:44-50.
26. Barker D.J., Osmond C., Golding J., Kuh D., Wadsworth M.E. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. Br Med J 1989, 298:564-567.
27. Barker D.J.P., Osmond C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet 1986, 327:1077-1081.
28. Lawlor D.A., Ronalds G., Clark H., Vey Smith G., Leon D.A. Birth weight is inversely associated with incident coronary heart disease and stroke among individuals born in the 1950s. Circulation 2005, 112:1414-1418.
29. Angelis E., Tse M.Y., Pang S.C. Interactions between atrial natriuretic peptide and the renin-angiotensin system during salt-sensitivity exhibited by the proANP gene-disrupted mouse. Mol Cell Biochem 2005, 276:121-131.
30. Burke S.D., Barrette V.F., Bianco J., Thorne J.G., Yamada A.T., Pang S.C., Adams M.A., Croy B.A. Spiral arterial remodeling is not essential for normal blood pressure regulation in pregnant mice. Hypertension 2010, 55:729-737.
31. Daugherty A., Rateri D., Hong L., Balakrishnan A. Measuring blood pressure in mice using volume pressure recording, a tail-cuff method. J. Vis. Exp. 2009, 27:e1291. 10.3791/1291.
32. Armstrong D.W.J., Tse M.Y., Melo L.G., Pang S.C. Altered expression of the natriuretic peptide system in genetically modified heme oxygenase-1 mice treated with high dietary salt. Mol Cell Biochem 2011, 346:57-67.
33. Tse M.Y., Watson J.D., Sarda I.R., Flynn T.G., Pang S.C. Expression of B-type natriuretic peptide in atrial natriuretic peptide gene disrupted mice. Mol Cell Biochem 2001, 219:99-105.
34. Vera N., Yat Tse M., Watson J.D., Sarda S., Steinhelper M.E., John S.W.M., Flynn T.G., Pang S.C. Altered expression of natriuretic peptide receptors in proANP gene disrupted mice. Cardiovasc Res 2000, 46:595-603.
35. Weir M.L., Pang S.C., Flynn T.G. Characterization of binding sites in rat for A, B and C-type natriuretic peptides. Regul Pept 1993, 47:291-305.
36. Maack T., Suzuki M., Almeida F.A., Nussenzveig D., Scarborough R.M., McEnroe G.A., Lewicki J.A. Physiological role of silent receptors of atrial natriuretic factor. Science 1987, 238:675-678.
37. Ananth C.V., Basso O. Impact of pregnancy-induced hypertension on stillbirth and neonatal mortality. Epidemiology 2010, 21:118-123.
38. Kato J., Kida O., Nakamura S., Sasaki A., Takiguchi K., Tanaka K. Dissociation between plasma and atrial content of atrial natriuretic polypeptide (ANP) following sodium load in rats. Life Sci 1986, 39:2623-2627.
39. Kumar P., Pandey K.N. Cooperative activation of Npr1 gene transcription and expression by interaction of Ets-1 and p300. Hypertension 2009, 54:172-178.
40. Levy D., Garrison R.J., Savage D.D., Kannel W.B., Castelli W.P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990, 322:1561-1566.
41. Koren M.J., Devereux R.B., Casale P.N., Savage D.D., Laragh J.H. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991, 114:345-352.
42. Verdecchia P., Carini G., Circo A., Dovellini E., Giovannini E., Lombardo M., Solinas P., Gorini M., Maggioni A.P. Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study. J Am Coll Cardiol 2001, 38:1829-1835. the MAVI Study Group.
43. Haider A.W., Larson M.G., Benjamin E.J., Levy D. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol 1998, 32:1454-1459.
44. Verdecchia P., Porcellati C., Reboldi G., Gattobigio R., Borgioni C., Pearson T.A., Ambrosio G. Left ventricular hypertrophy as an independent predictor of acute cerebrovascular events in essential hypertension. Circulation 2001, 104:2039-2044.
45. Schillaci G., Verdecchia P., Porcellati C., Cuccurullo O., Cosco C., Perticone F. Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension 2000, 35:580-586.
46. Verdecchia P., Schillaci G., Borgioni C., Ciucci A., Gattobigio R., Zampi I., Reboldi G., Porcellati C. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 1998, 97:48-54.
47. Vincent M., Kaiser M.A., Orea V., Lodwick D., Samani N.J. Hypertension in the spontaneously hypertensive rat and the sex chromosomes. Hypertension 1994, 23:161-166.
48. Geelhoed J.J.M., Fraser A., Tilling K., Benfield L., Vey Smith G., Sattar N., Nelson S.M., Lawlor D.A. Preeclampsia and gestational hypertension are associated with childhood blood pressure independently of family adiposity measures/clinical perspective. Circulation 2010, 122:1192-1199.
49. Tenhola S., Rahiala E., Halonen P., Vanninen E., Voutilainen R. Maternal preeclampsia predicts elevated blood pressure in 12-year-old children: evaluation by ambulatory blood pressure monitoring. Pediatr Res 2006, 59:320-324.
50. Davis E.F., Lazdam M., Lewandowski A.J., Worton S.A., Kelly B., Kenworthy Y., Adwani S., Wilkinson A.R., McCormick K., Sargent I., Redman C., Leeson P. Cardiovascular risk factors in children and young adults born to preeclamptic pregnancies: a systematic review. Pediatrics 2012, 129:e1552-e1561.
51. Charron F., Nemer M. GATA transcription factors and cardiac development. Semin Cell Dev Biol 1999, 10:85-91.
52. Pan J., Hinzmann B., Yan W., Wu F., Morser J., Wu Q. Genomic structures of the human and murine corin genes and functional GATA elements in their promoters. J Biol Chem 2002, 277:38390-38398.
53. Oliver P.M., John S.W.M., Purdy K.E., Kim R., Maeda N., Goy M.F., Smithies O. Natriuretic peptide receptor 1 expression influences blood pressures of mice in a dose-dependent manner. Proc Natl Acad Sci U S A 1998, 95:2547-2551.
54. Shi S.J., Vellaichamy E., Chin S.Y., Smithies O., Navar L.G., Pandey K.N. Natriuretic peptide receptor A mediates renal sodium excretory responses to blood volume expansion. Am J Physiol Renal Physiol 2003, 285:F694-F702.
55. Martin F.L., Supaporn T., Chen H.H., Sandberg S.M., Matsuda Y., Jougasaki M., Burnett J.C. Distinct roles for renal particulate and soluble guanylyl cyclases in preserving renal function in experimental acute heart failure. Am J Physiol Regul Integr Comp Physiol 2007, 293:R1580-R1585.
56. Matsukawa N., Grzesik W.J., Takahashi N., Pandey K.N., Pang S., Yamauchi M., Smithies O. The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc Natl Acad Sci U S A 1999, 96:7403-7408.
57. Hamet P., Pang S.C., Tremblay J. Atrial natriuretic factor-induced egression of cyclic guanosine 3': 5'-monophosphate in cultured vascular smooth muscle and endothelial cells. J Biol Chem 1989, 264:12364-12369.